A Phase II Study of Obinutuzumab in Combination with Ibrutinib for Treatment of Relapsed Mantle Cell Lymphoma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Overview
Authors
Affiliations